0001144204-13-057817.txt : 20131031 0001144204-13-057817.hdr.sgml : 20131031 20131030195832 ACCESSION NUMBER: 0001144204-13-057817 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131031 DATE AS OF CHANGE: 20131030 EFFECTIVENESS DATE: 20131031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTI SCIENCE, INC. CENTRAL INDEX KEY: 0001431739 IRS NUMBER: 261334146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-165072 FILM NUMBER: 131180540 BUSINESS ADDRESS: STREET 1: 2430 PALUMBO DRIVE STREET 2: SUITE 140 CITY: LEXINGTON STATE: KY ZIP: 40509 BUSINESS PHONE: 859-266-9200 MAIL ADDRESS: STREET 1: 2430 PALUMBO DRIVE STREET 2: SUITE 140 CITY: LEXINGTON STATE: KY ZIP: 40509 FORMER COMPANY: FORMER CONFORMED NAME: CTI SCIENCE INC DATE OF NAME CHANGE: 20080407 D/A 1 primary_doc.xml X0707 D/A LIVE 0001431739 CTI SCIENCE, INC. 2430 PALUMBO DRIVE SUITE 140 LEXINGTON KY KENTUCKY 40509-1117 859-266-9200 DELAWARE Chelator Technologies, Inc. CTI SCIENCE INC Corporation true Boyd E. Haley 2430 PALUMBO DRIVE SUITE 140 LEXINGTON KY KENTUCKY 40509-1117 Executive Officer Director Promoter J. Todd Renner 2430 PALUMBO DRIVE SUITE 140 LEXINGTON KY KENTUCKY 40509-1117 Executive Officer Kathryn M. Wachsman 55 WALL STREET SUITE 838 NEW YORK NY NEW YORK 10005 Executive Officer Director Ragnar Klingberg BRANTINGSGATAN 42, 2TR STOCKHOLM V7 SWEDEN 11535 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001144204-11-050260 2011-08-15 false true false 0 5000000 3702210 1297790 false 15 0 0 0 false CTI SCIENCE, INC. /s/ J. Todd Renner, CPA, CGMA J. Todd Renner Chief Financial Officer 2013-10-30